Background:Bone metastasis is very frequent in prostate cancer.
It is a turning point that marks the severity of the disease. Before metastasis become symptomatic, treatment preventing bone events should be indicated.
Aim:To evaluate the role of bisphosphonate in the treatment of bone metastases from prostate cancer.
Methods:A review of literature
Results:Bisphosphonates play a very important role to prevent bone mass loss and to reduce bone complication events.
Conclusion: Bisphosphonates are recommended as preventive treatment at the time of diagnosis of bone metastatic prostate cancer.
Written by:
Sallami S, Ben Rhouma S, Cherif K, Benrais N, Horchani A. Are you the author?
Reference: Tunis Med. 2012 Jul;90(7):507-11.
PubMed Abstract
PMID: 22811222
UroToday.com Prostate Cancer Section
